New York, New York - October 3, 2012 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector for independent investors issues a trading alert for NASDAQ’s top percentage gainer, Sarepta Therapeutics (NASDAQ:SRPT), up a whopping 182% . The stock is trading at $42.32, moving 27.33 or 182.32% as of 2:25PM EDT on over 23 Million shares.
The Company today reported that treatment with its lead exon-skipping compound, eteplirsen, met the primary efficacy endpoint, increase in novel dystrophin, and achieved a significant clinical benefit on the primary clinical outcome, the 6-minute walk test (6MWT) over the placebo/delayed treatment cohort in a Phase IIb extension trial in Duchenne muscular dystrophy (DMD) patients.
- Published: 03 October 2012
- Written by Investor Ideas